G protein-coupled receptor 43 moderates gut inflammation through cytokine regulation from mononuclear cells

Inflammatory Bowel Diseases

Volumn 19, Issue 13, 2013, Pages 2848-2856

  Masui, Ryuta ^a   Sasaki, Makoto ^a   Funaki, Yasushi ^a   Ogasawara, Naotaka ^a   Mizuno, Mari ^a   Iida, Akihito ^a   Izawa, Shinya ^a   Kondo, Yoshihiro ^a   Ito, Yoshitsugi ^a   Tamura, Yasuhiro ^a   Yanamoto, Kenichiro ^a   Noda, Hisatsugu ^a   Tanabe, Atsushi ^a   Okaniwa, Noriko ^a   Yamaguchi, Yoshiharu ^a   Iwamoto, Takashi ^b   Kasugai, Kunio ^a  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CHUBU UNIVERSITY   (Japan)

Author keywords

Colitis; Cytokine; GPR43; Lymphocyte; SCFAs

Indexed keywords

ACETIC ACID; DEXTRAN SULFATE; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 43; INTERLEUKIN 10; INTERLEUKIN 17; SHORT CHAIN FATTY ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTEROIDES; CLOSTRIDIUM; COLITIS; COLON MUCOSA; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ACTIVITY; FEMALE; GENE INACTIVATION; INTESTINE FLORA; LACTOBACILLALES; MICROBIAL COMMUNITY; MONONUCLEAR CELL; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PREVOTELLA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; UPREGULATION; WEIGHT REDUCTION; WILD TYPE;

ANIMALS; CYTOKINES; DEXTRAN SULFATE; ENTEROCOLITIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACIDS, VOLATILE; FEMALE; GASTROINTESTINAL TRACT; INTESTINAL MUCOSA; LEUKOCYTES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84893794477     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/01.MIB.0000435444.14860.ea     Document Type: Article

References (32)

1. Araki Y, Andoh A, Fujiyama Y, et al. In vitro alterations in fecal short chain fatty acids and organic anions induced by the destruction of intestinal microflora under hypotonic and aerobic conditions. Int J Mol Med. 2002;9:627-631.
2. Vernia P, Gnaedinger A, Hauck W, et al. Organic anions and the diarrhea of inflammatory bowel disease. Dig Dis Sci. 1988;33:1353-1358.
3. Hamer HM, Jonkers D, Venema K, et al. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther. 2008;27:104-119.
4. Marchesi JR, Holmes E, Khan F, et al. Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res. 2007;6:546-551.
5. Scheppach W, Weiler F. The butyrate story: old wine in new bottles? Curr Opin Clin Nutr Metab Care. 2004;7:563-567.
6. Harig JM, Soergel KH, Komorowski RA, et al. Treatment of diversion colitis with short-chain-fatty acid irrigation. N Engl J Med. 1989;320:23-28.
7. Breuer RI, Buto SK, Christ ML, et al. Rectal irrigation with short-chain fatty acids for distal ulcerative colitis. Preliminary report. Dig Dis Sci. 1991;36:185-187.
8. Brown AJ, Goldsworthy SM, Barnes AA, et al. The Orphan G proteincoupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem. 2003;278:11312-11319.
9. Nilsson NE, Kotarsky K, Owman C, et al. Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids. Biochem Biophys Res Commun. 2003;303:1047-1052.
10. Senga T, Iwamoto S, Yoshida T, et al. LSSIG is a novel murine leukocytespecific GPCR that is induced by the activation of STAT3. Blood. 2003; 101:1185-1187.
11. Le Poul E, Loison C, Struyf S, et al. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem. 2003;278:25481-25489.
12. Yonezawa T, Kobayashi Y, Obara Y. Short-chain fatty acids induce acute phosphorylation of the p38 mitogen-activated protein kinase/heat shock protein 27 pathway via GPR43 in the MCF-7 human breast cancer cell line. Cell Signal. 2007;19:185-193.
13. Sina C, Gavrilova O, Forster M, et al. G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation. J Immunol. 2009;183:7514-7522.
14. Maslowski KM, Vieira AT, Ng A, et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature. 2009;461:1282-1286.
15. Dieleman LA, Palmen MJ, Akol H, et al. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol. 1998;114:385-391.
16. Zhu H, Qu F, Zhu LH. Isolation of genomic DNAs from plants, fungi and bacteria using benzyl chloride. Nucleic Acids Res. 1993;21:5279-5280.
17. Nagashima K, Hisada T, Sato M, et al. Application of new primer-enzyme combinations to terminal restriction fragment length polymorphism profiling of bacterial populations in human feces. Appl Environ Microbiol. 2003;69:1251-1262.
18. Dieleman LA, Pena AS, Meuwissen SG, et al. Role of animal models for the pathogenesis and treatment of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1997;223:99-104.
19. Gibson DL, Ma C, Rosenberger CM, et al. Toll-like receptor 2 plays a critical role in maintaining mucosal integrity during Citrobacter rodentiuminduced colitis. Cell Microbiol. 2008;10:388-403.
20. Alhawi M, Stewart J, Erridge C, et al. Bacteroides fragilis signals through Toll-like receptor (TLR) 2 and not through TLR4. J Med Microbiol. 2009; 58:1015-1022.
21. Andoh A, Tsujikawa T, Sasaki M, et al. Faecal microbiota profile of Crohn's disease determined by terminal restriction fragment length polymorphism analysis. Aliment Pharmacol Ther. 2009;29:75-82.
22. Chapman MA, Grahn MF, Boyle MA, et al. Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis. Gut. 1994;35:73-76.
23. Breuer RI, Soergel KH, Lashner BA, et al. Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial. Gut. 1997;40:485-491.
24. Segain JP, Raingeard de la Bletiere D, Bourreille A, et al. Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. Gut. 2000;47:397-403.
25. Tedelind S, Westberg F, Kjerrulf M, et al. Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. World J Gastroenterol. 2007;13:2826-2832.
26. Cavaglieri CR, Nishiyama A, Fernandes LC, et al. Differential effects of short-chain fatty acids on proliferation and production of pro-and anti-inflammatory cytokines by cultured lymphocytes. Life Sci. 2003;73:1683-1690.
27. Luhrs H, Kudlich T, Neumann M, et al. Butyrate-enhanced TNFalphainduced apoptosis is associated with inhibition of NF-kappaB. Anticancer Res. 2002;22:1561-1568.
28. Ishiguro K, Ando T, Maeda O, et al. Acetate inhibits NFAT activation in T cells via importin beta1 interference. Eur J Immunol. 2007;37: 2309-2316.
29. Kovarik JJ, Tillinger W, Hofer J, et al. Impaired anti-inflammatory efficacy of n-butyrate in patients with IBD. Eur J Clin Invest. 2011;41:291-298.
30. Kim MH, Kang SG, Park JH, et al. Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice. Gastroenterology. 2013;145:396-406.
31. Ogawa H, Rafiee P, Fisher PJ, et al. Butyrate modulates gene and protein expression in human intestinal endothelial cells. Biochem Biophys Res Commun. 2003;309:512-519.
32. Ogawa H, Rafiee P, Fisher PJ, et al. Sodium butyrate inhibits angiogenesis of human intestinal microvascular endothelial cells through COX-2 inhibition. FEBS Lett. 2003;554:88-94.